Search


	Podcast:		The Bio Report
	Episode:		Taking a Portfolio Approach to Immuno-Oncology
	Category:		Business
	Duration:		00:33:13
	Publish Date:		2021-08-05 08:00:14
	Description:		While the class of immunotherapies known as checkpoint inhibitors has brought a promising new approach to treating cancer, the development of resistance to these therapies limits the number of patients they benefit. Portage Biotech is building a set of platform technologies and a pipeline of immuno-oncology therapeutic candidates to address this problem. We spoke to Ian Walters, CEO of Portage about the problem of resistance, the company’s pipeline of candidates, and its portfolio-based business model.
	Total Play:		0

Some more Podcasts by Levine Media Group

600+ Episodes

The Bio Repo ..